David Larsen
Stock Analyst at BTIG
(2.12)
# 2,940
Out of 4,963 analysts
77
Total ratings
36.67%
Success rate
-0.85%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Buy | $335 → $340 | $277.24 | +22.64% | 2 | Aug 28, 2025 | |
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $14.23 | +75.69% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $8.87 | +12.80% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $68.74 | +16.38% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $22.88 | +22.38% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $44.06 | -20.55% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $87.51 | +48.55% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $26.46 | +17.18% | 3 | Nov 11, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $260 | $187.94 | +38.34% | 2 | Nov 1, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $15 → $20 | $24.06 | -16.86% | 2 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $70 | $30.79 | +127.35% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $4.05 | +73.05% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.61 | +334.78% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.40 | +118.75% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.10 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.18 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $45 | $9.70 | +363.92% | 4 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $21 | $3.71 | +466.04% | 3 | Sep 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.25 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $21.62 | +61.92% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.73 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $7.00 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $149.23 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $682.00 | -76.54% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $75 → $70 | $12.04 | +481.40% | 3 | May 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $68.54 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $71.27 | +19.26% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $4.77 | +382.18% | 1 | Nov 2, 2017 |
Veeva Systems
Aug 28, 2025
Maintains: Buy
Price Target: $335 → $340
Current: $277.24
Upside: +22.64%
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $14.23
Upside: +75.69%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.87
Upside: +12.80%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $68.74
Upside: +16.38%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $22.88
Upside: +22.38%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $44.06
Upside: -20.55%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $87.51
Upside: +48.55%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $26.46
Upside: +17.18%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $187.94
Upside: +38.34%
BrightSpring Health Services
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $24.06
Upside: -16.86%
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $30.79
Upside: +127.35%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.05
Upside: +73.05%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.61
Upside: +334.78%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.40
Upside: +118.75%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.10
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $33.18
Upside: -
Oct 12, 2022
Maintains: Buy
Price Target: $55 → $45
Current: $9.70
Upside: +363.92%
Sep 26, 2022
Maintains: Buy
Price Target: $25 → $21
Current: $3.71
Upside: +466.04%
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.25
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $21.62
Upside: +61.92%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.73
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $7.00
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $149.23
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $682.00
Upside: -76.54%
May 23, 2018
Maintains: Market Perform
Price Target: $75 → $70
Current: $12.04
Upside: +481.40%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $68.54
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $71.27
Upside: +19.26%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $4.77
Upside: +382.18%